|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/22/13 Kraig Biocraft Laboratories, Inc 8-K:5,9 11/15/13 2:678K Issuer Direct/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 20K 2: EX-3.1 Articles of Amendment HTML 5K
|
Wyoming
|
83-0459707
|
|||
|
(State of Incorporation)
|
(Commission File No.)
|
(IRS Employer
Identification Number)
|
|
120 N. Washington Square, Suite 805, Lansing, Michigan
|
48933
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
|
|
o
|
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
|
|
-
|
a new Article 9 to read as follows: “Article 9. Any public notice or notice to the shareholders, including notice of meetings of the shareholders and notices which are permitted or required by law to shareholders, may be made by publication on the Company’s website, or by other electronic means, to the extent that such means of publication are allowed by applicable law.”
|
|
-
|
a new Article 10 to read as follows: “Article 10. Any action permitted to be taken at a shareholders' meeting may be taken without a meeting, and without prior notice, if consents in writing setting forth the action so taken are signed by the holders of outstanding shares having not less than the minimum number of votes that would be required to authorize or take the action at a meeting at which all shares entitled to vote on the action were present and voted.”
|
|
-
|
a new Article 11 to read as follows: “Article 11. The Board of Directors is expressly authorized at any time, and from time to time, to (x) classify any unissued shares in one or more classes or in one or more series within a class, (y) reclassify any unissued shares of any class into one (1) or more classes or into one (1) or more series within one (1) or more classes, or (z) reclassify any unissued shares of any series of any class into one (1) or more classes or into one (1) or more series within a class; with such voting powers and such designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions providing for the issue thereof adopted by the Board of Directors, and as are not stated and expressed in these Articles
of Incorporation, or any amendment thereto.”
|
|
Exhibit No.
|
Description
|
|
|
Articles of Amendment
|
|
Kraig Biocraft Laboratories, Inc.
|
|||
|
Dated: November 22, 2013
|
By:
|
/s/ Kim Thompson
|
|
|
Name: Kim Thompson
|
|||
|
Title: Chief Executive Officer
|
|||
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/22/13 | None on these Dates | ||
| For Period End: | 11/15/13 | |||
| List all Filings | ||||